Wilmington Savings Fund Society FSB Sells 35,347 Shares of Masimo Co. (NASDAQ:MASI)

Wilmington Savings Fund Society FSB decreased its holdings in Masimo Co. (NASDAQ:MASI - Free Report) by 72.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,717 shares of the medical equipment provider's stock after selling 35,347 shares during the quarter. Wilmington Savings Fund Society FSB's holdings in Masimo were worth $2,267,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in MASI. Blue Trust Inc. increased its position in Masimo by 56.3% during the fourth quarter. Blue Trust Inc. now owns 197 shares of the medical equipment provider's stock worth $33,000 after buying an additional 71 shares during the last quarter. NBC Securities Inc. raised its position in Masimo by 47.1% in the third quarter. NBC Securities Inc. now owns 228 shares of the medical equipment provider's stock worth $30,000 after purchasing an additional 73 shares in the last quarter. MML Investors Services LLC raised its position in Masimo by 4.9% in the third quarter. MML Investors Services LLC now owns 2,056 shares of the medical equipment provider's stock worth $274,000 after purchasing an additional 96 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Masimo by 180.9% during the fourth quarter. UMB Bank n.a. now owns 191 shares of the medical equipment provider's stock worth $32,000 after buying an additional 123 shares in the last quarter. Finally, Assetmark Inc. increased its holdings in shares of Masimo by 12.7% during the third quarter. Assetmark Inc. now owns 1,183 shares of the medical equipment provider's stock worth $158,000 after buying an additional 133 shares in the last quarter. Institutional investors and hedge funds own 85.96% of the company's stock.

Masimo Stock Up 0.0 %

Shares of Masimo stock traded up $0.08 during trading hours on Thursday, reaching $179.59. The company's stock had a trading volume of 290,031 shares, compared to its average volume of 455,387. Masimo Co. has a one year low of $101.61 and a one year high of $183.14. The company has a market capitalization of $9.62 billion, a P/E ratio of 123.86 and a beta of 1.02. The stock's fifty day simple moving average is $171.98 and its two-hundred day simple moving average is $148.54. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.11 and a current ratio of 2.01.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Piper Sandler raised their price target on shares of Masimo from $180.00 to $210.00 and gave the company an "overweight" rating in a report on Wednesday, December 18th. Raymond James lifted their price target on shares of Masimo from $170.00 to $194.00 and gave the stock an "outperform" rating in a research report on Friday, December 27th. Needham & Company LLC reiterated a "hold" rating on shares of Masimo in a research note on Wednesday, January 22nd. Stifel Nicolaus restated a "buy" rating and set a $190.00 price objective (up from $170.00) on shares of Masimo in a research note on Friday, November 22nd. Finally, Wells Fargo & Company boosted their price objective on shares of Masimo from $171.00 to $193.00 and gave the company an "overweight" rating in a report on Wednesday, December 11th. Two research analysts have rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat.com, Masimo presently has an average rating of "Moderate Buy" and an average target price of $191.40.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.